Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.42 Analyst target: $4.46 Upside: 214.44%
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.